Listar Investigación y Desarrollo por autor "Camins A."
Mostrando ítems 1-20 de 24
-
Review
A metabolic perspective of late onset Alzheimer's disease (2020)
Ettcheto M.; Cano A.; Busquets O.; Manzine P.R.; Sánchez-López E.; Castro-Torres R.D.; Beas-Zarate C.; Verdaguer E.; García M.L.; Olloquequi J.; ... (Academic Press, 2019) -
Review
ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker (2020)
Manzine P.R.; Ettcheto M.; Cano A.; Busquets O.; Marcello E.; Pelucchi S.; Di Luca M.; Endres K.; Olloquequi J.; Camins A.; ... (Elsevier Masson SAS, 2019) -
Article
Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia (2020)
Ettcheto M.; Olloquequi J.; Sánchez-López E.; Busquets O.; Cano A.; Manzine P.R.; Beas-Zarate C.; Castro-Torres R.D.; García M.L.; Bulló M.; ... (Frontiers Media S.A., 2020) -
Article
c-Jun N-terminal Kinase 1 ablation protects against metabolic-induced hippocampal cognitive impairments (2020)
Busquets O.; Ettcheto M.; Eritja À.; Espinosa-Jiménez T.; Verdaguer E.; Olloquequi J.; Beas-Zarate C.; Castro-Torres R.D.; Casadesús G.; Auladell C.; ... (Springer, 2019) -
Review
Current Research Therapeutic Strategies for Alzheimer's Disease Treatment (2020)
Folch J.; Petrov D.; Ettcheto M.; Abad S.; Sánchez-López E.; García M.L.; Olloquequi J.; Beas-Zarate C.; Auladell C.; Camins A. (Hindawi Publishing Corporation, 2016) -
Article
Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways (2020)
Ettcheto M.; Sánchez-López E.; Pons L.; Busquets O.; Olloquequi J.; Beas-Zarate C.; Pallas M.; García M.L.; Auladell C.; Folch J.; ... (Elsevier B.V., 2017) -
Article
Early Preclinical Changes in Hippocampal CREB-Binding Protein Expression in a Mouse Model of Familial Alzheimer’s Disease (2020)
Ettcheto M.; Abad S.; Petrov D.; Pedrós I.; Busquets O.; Sánchez-López E.; Casadesús G.; Beas-Zarate C.; Carro E.; Auladell C.; ... (Humana Press Inc., 2018) -
Article
Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice (2020)
Ettcheto M.; Cano A.; Manzine P.R.; Busquets O.; Verdaguer E.; Castro-Torres R.D.; García M.L.; Beas-Zarate C.; Olloquequi J.; Auladell C.; ... (Springer, 2020) -
Review
Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications (2020)
Olloquequi J.; Cornejo-Córdova E.; Verdaguer E.; Soriano F.X.; Binvignat O.; Auladell C.; Camins A. (SAGE Publications Ltd, 2018) -
Review
Experimental models for aging and their potential for novel drug discovery (2020)
Folch J.; Busquets O.; Ettcheto M.; Sánchez-López E.; Pallàs M.; Beas-Zarate C.; Marin M.; Casadesus G.; Olloquequi J.; Auladell C.; ... (Bentham Science Publishers B.V., 2018) -
Review
Involvement of JNK1 in Neuronal Polarization During Brain Development (2020)
Castro-Torres R.D.; Busquets O.; Parcerisas A.; Verdaguer E.; Olloquequi J.; Etchetto M.; Beas-Zarate C.; Folch J.; Camins A.; Auladell C. (NLM (Medline), 2020) -
Article
JNK Isoforms Are Involved in the Control of Adult Hippocampal Neurogenesis in Mice, Both in Physiological Conditions and in an Experimental Model of Temporal Lobe Epilepsy (2020)
Castro-Torres R.D.; Landa J.; Rabaza M.; Busquets O.; Olloquequi J.; Ettcheto M.; Beas-Zarate C.; Folch J.; Camins A.; Auladell C.; ... (Humana Press Inc., 2019) -
Review
Masitinib for the treatment of mild to moderate Alzheimer's disease (2020)
Folch J.; Petrov D.; Ettcheto M.; Pedrós I.; Abad S.; Beas-Zarate C.; Lazarowski A.; Marin M.; Olloquequi J.; Auladell C.; ... (Expert Reviews Ltd., 2015) -
Review
Memantine for the treatment of dementia: A review on its current and future applications (2020)
Folch J.; Busquets O.; Ettcheto M.; Sánchez-López E.; Castro-Torres R.D.; Verdaguer E.; Garcia M.L.; Olloquequi J.; Casadesús G.; Beas-Zarate C.; ... (IOS Press, 2018) -
Article
Neuroprotective Effects of the Absence of JNK1 or JNK3 Isoforms on Kainic Acid-Induced Temporal Lobe Epilepsy-Like Symptoms (2020)
de Lemos L.; Junyent F.; Camins A.; Castro-Torres R.D.; Folch J.; Olloquequi J.; Beas-Zarate C.; Verdaguer E.; Auladell C. (Humana Press Inc., 2018) -
Short Survey
Review of the advances in treatment for Alzheimer disease: Strategies for combating β-amyloid protein [Una revisión de los avances en la terapéutica de la enfermedad de Alzheimer: estrategia frente a la proteína β-amiloide] (2020)
Folch J.; Ettcheto M.; Petrov D.; Abad S.; Pedrós I.; Marin M.; Olloquequi J.; Camins A. (Spanish Society of Neurology, 2018) -
Article
Role of brain c-Jun N-terminal kinase 2 in the control of the insulin receptor and its relationship with cognitive performance in a high-fat diet pre-clinical model (2020)
Busquets O.; Eritja À.; López B.M.; Ettcheto M.; Manzine P.R.; Castro-Torres R.D.; Verdaguer E.; Olloquequi J.; Vázquez-Carrera M.; Auladell C.; ... (Blackwell Publishing Ltd, 2019) -
Review
Role of c-jun N-terminal kinases (JNKs) in epilepsy and metabolic cognitive impairment (2020)
Busquets O.; Ettcheto M.; Cano A.; Manzine P.R.; Sánchez-Lopez E.; Espinosa-Jiménez T.; Verdaguer E.; Castro-Torres R.D.; Beas-Zarate C.; Sureda F.X.; ... (MDPI AG, 2020) -
Review
Role of JNK isoforms in the kainic acid experimental model of epilepsy and neurodegeneration (2020)
Auladell C.; De Lemos L.; Verdaguer E.; Ettcheto M.; Busquets O.; Lazarowski A.; Beas-Zarate C.; Olloquequi J.; Folch J.; Camins A. (Frontiers in Bioscience, 2017) -
Article
The implication of the brain insulin receptor in late onset Alzheimer’s disease dementia (2020)
Folch J.; Ettcheto M.; Busquets O.; Sánchez-López E.; Castro-Torres R.D.; Verdaguer E.; Manzine P.R.; Poor S.R.; García M.L.; Olloquequi J.; ... (MDPI AG, 2018)